Sinco Pharmaceuticals Holdings Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Min Jin
Chief executive officer
CN¥1.7m
Total compensation
CEO salary percentage | 94.0% |
CEO tenure | less than a year |
CEO ownership | 0.7% |
Management average tenure | 2.2yrs |
Board average tenure | 6.7yrs |
Recent management updates
Recent updates
Sinco Pharmaceuticals Holdings Limited (HKG:6833) Might Not Be As Mispriced As It Looks
Mar 08Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?
Nov 07A Look At The Intrinsic Value Of Sinco Pharmaceuticals Holdings Limited (HKG:6833)
Jun 26Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?
May 30Sinco Pharmaceuticals Holdings (HKG:6833) Has A Pretty Healthy Balance Sheet
Oct 26Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Might Deserve Your Attention Today
Feb 04I Ran A Stock Scan For Earnings Growth And Sinco Pharmaceuticals Holdings (HKG:6833) Passed With Ease
Oct 25Little Excitement Around Sinco Pharmaceuticals Holdings Limited's (HKG:6833) Earnings
Jun 10Sinco Pharmaceuticals Holdings (HKG:6833) Could Easily Take On More Debt
May 24Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Is An Interesting Stock
Apr 20We're Not So Sure You Should Rely on Sinco Pharmaceuticals Holdings' (HKG:6833) Statutory Earnings
Feb 16How Much Did Sinco Pharmaceuticals Holdings'(HKG:6833) Shareholders Earn From Share Price Movements Over The Last Three Years?
Jan 11Should You Be Excited About Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 51% Return On Equity?
Dec 07CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2023 | n/a | n/a | CN¥27m |
Mar 31 2023 | n/a | n/a | CN¥48m |
Dec 31 2022 | CN¥2m | CN¥2m | CN¥69m |
Compensation vs Market: Min's total compensation ($USD229.49K) is about average for companies of similar size in the Hong Kong market ($USD234.61K).
Compensation vs Earnings: Insufficient data to compare Min's compensation with company performance.
CEO
Min Jin (45 yo)
less than a year
Tenure
CN¥1,659,000
Compensation
Mr. Min Jin was Co-Chief Executive Officer at Sinco Pharmaceuticals Holdings Limited since November 2020 until March 29, 2023. He has experience in the pharmaceutical industry. He served as Director of mar...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive Chairman | 12.9yrs | CN¥4.11m | 51.65% CN¥ 257.2m | |
Chief Executive Officer | less than a year | CN¥1.66m | 0.67% CN¥ 3.4m | |
Chief Financial Officer | 8.8yrs | no data | no data | |
Executive Director | no data | no data | no data | |
Joint Company Secretary | 4.4yrs | no data | no data | |
Joint Company Secretary | 3yrs | no data | no data | |
President of Sichuan Sinco Pharmaceuticals Co. Ltd. | 1.3yrs | no data | no data |
2.2yrs
Average Tenure
43yo
Average Age
Experienced Management: 6833's management team is considered experienced (2.2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive Chairman | 12.9yrs | CN¥4.11m | 51.65% CN¥ 257.2m | |
Executive Director | less than a year | no data | no data | |
Independent Non-Executive Director | 5.3yrs | CN¥190.00k | no data | |
Independent Non-Executive Director | 8.1yrs | CN¥190.00k | no data | |
Independent Non-Executive Director | 8.1yrs | CN¥190.00k | no data | |
Independent Non-Executive Director | 3.5yrs | CN¥190.00k | no data |
6.7yrs
Average Tenure
57yo
Average Age
Experienced Board: 6833's board of directors are considered experienced (6.7 years average tenure).